ChiCTR2000040658: Evaluating safety and immunogenicity of a quadrivalent inactived subunit influenza virus vaccine after injection in healthy people aged 6 months and above: a randomised, double-blind, positive-controlled phase I clinical trial |
|
|
| Completed | 1 | 320 | | 2 low dose of trial vaccine(subunit quadrivalent inactived subunit influenza virus vaccine) for 28 days interval (+/- 7days) ;2 high dose of trial vaccine(subunit quadrivalent inactived subunit influenza virus vaccine) for 28 days interval (+/- 7days) ;2 high dose of trial vaccine(subunit quadrivalent inactived subunit influenza virus vaccine) ;2 dose of control vaccine(split-virion quadrivalent inactived subunit influenza virus vaccine) ;1 high dose of trial vaccine(subunit quadrivalent inactived subunit influenza virus vaccine) ;1 dose of control vaccine(split-virion quadrivalent inactived subunit influenza virus vaccine) ;1 high dose of trial vaccine(subunit quadrivalent inactived subunit influenza virus vaccine) ;1 dose of control vaccine(split-virion quadrivalent inactived subunit influenza virus vaccine) | Henan Provincial Center for Disease Control and Prevention; Center for Ab&b Biotechnology Co., Ltd, Center for Ab&b Biotechnology Co., Ltd | inlfuenza virus infection | | | | |
